Results 271 to 280 of about 123,724 (326)
Molekularer Mechanismus der Fas Ligand-induzierten Aktivierung der sauren Sphingomyelinase
Mario Stephan
openalex +1 more source
Some of the next articles are maybe not open access.
Related searches:
Related searches:
Fas, Fas ligand,and transfusion immunomodulation
Transfusion, 2001dem-onstrated that soluble HLA class I (sHLA-I) moleculesupregulate FasL expression and sFasL secretion in activatedFas-positive CD8+ T-cells and trigger their apoptosis. Thelevel of sHLA-I molecules is significantly increased in theserum of patients with an activation of their immune sys-tem, such as occurs during acute rejection of organ al-lografts,
PUPPO, FRANCESCO +4 more
openaire +3 more sources
Fas/Fas ligand and hematopoietic progenitor cells
Current Opinion in Hematology, 1998Fas antigen is a receptor that crosslinks with a ligand or antibody initiating a signal transduction cascade that leads to apoptosis. During normal hematopoiesis, Fas antigen is not expressed on CD34+ cells, including premature hematopoietic progenitor cells. Functioning Fas antigen expression is induced by several hematopoietic regulators.
Y, Niho, Y, Asano
openaire +2 more sources
Structure and Function of Fas/Fas Ligand
International Reviews of Immunology, 1999Fas is a member of the TNF receptor family, that contain 2-6 cysteine-rich domains (CRDs) in their extracellular regions, a single transmembrane domain and variably sized intracytoplasmic domains. Fas belongs to a subgroup of family members that have a "death domain" near the carboxy-terminal region of the molecule.
J R, Orlinick, A K, Vaishnaw, K B, Elkon
openaire +2 more sources
Fas ligand: receptor or ligand?
Apoptosis, 1999In this review, we chronicle the discovery, biochemical characterization, and assignment of Fas (CD95) as receptor and Fas Ligand (FasL, CD95L) as ligand. We review the functional descriptions of the molecules as death-inducing receptor and ligand or as mediators of cell division and/or growth arrest.
M K, Newell, J, Desbarats
openaire +2 more sources
Annual Review of Genetics, 1999
▪ Abstract The immune response is regulated not only by cell proliferation and differentiation, but also by programmed cell death, or apoptosis. In response to various stimuli, death factors bind to their respective receptors and activate the apoptotic death program in target cells.
openaire +2 more sources
▪ Abstract The immune response is regulated not only by cell proliferation and differentiation, but also by programmed cell death, or apoptosis. In response to various stimuli, death factors bind to their respective receptors and activate the apoptotic death program in target cells.
openaire +2 more sources
Expression of Fas‐Fas Ligand in Murine Testis
American Journal of Reproductive Immunology, 1999Xu JP, Li X, Mori E, Guo MW, Matsuda I, Takaichi H, Amano T, Mori T. Expression of Fas‐Fas ligand in murine testis. AJRI 1999; 42:381–388 © Munksgaard, CopenhagenPROBLEM: During spermatogenesis, it has been suggested that the number of germ cells to be matured is regulated and restricted through the apoptotic mechanism.
J P, Xu +7 more
openaire +2 more sources
Targeting the Fas/Fas ligand pathway in cancer
Expert Opinion on Therapeutic Targets, 2005Fas is a transmembrane receptor that can induce apoptosis after cross-linking with either agonistic antibodies or with Fas ligand (FasL). Although originally described as an important regulator of peripheral immune homeostasis, accumulating evidence suggests that the Fas/FasL system plays an important role in tumour development.
Darren I, O'Brien +5 more
openaire +2 more sources
Fas and Fas ligand: lpr and gld mutations
Immunology Today, 1995Fas ligand (FasL) is a death factor that binds to its receptor, Fas, and induces apoptosis. Two mutations that accelerate autoimmune disease, lpr and gld, are known to correspond to mutations within genes encoding Fas and FasL, respectively. Here, Shigekazu Nagata and Takashi Suda summarize current knowledge of Fas and FasL, and discuss the ...
S, Nagata, T, Suda
openaire +2 more sources

